Lederman Seth

Lederman Seth is listed in filings as Chief Executive Officer at Tonix Pharmaceuticals Holding Corp.. This profile follows SEC Form 4 activity through Jun 9, 2026, including purchase activity. Recent filings connect the profile to Tonix Pharmaceuticals Holding Corp. (TNXP). The current snapshot covers public activity from Feb 27, 2025 to Jun 9, 2026. Reported amounts are shown as $59.0K to $18. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.